全文获取类型
收费全文 | 25080篇 |
免费 | 1099篇 |
国内免费 | 46篇 |
专业分类
耳鼻咽喉 | 439篇 |
儿科学 | 808篇 |
妇产科学 | 546篇 |
基础医学 | 4113篇 |
口腔科学 | 574篇 |
临床医学 | 1913篇 |
内科学 | 4565篇 |
皮肤病学 | 858篇 |
神经病学 | 2490篇 |
特种医学 | 1219篇 |
外国民族医学 | 23篇 |
外科学 | 3352篇 |
综合类 | 89篇 |
一般理论 | 11篇 |
预防医学 | 1439篇 |
眼科学 | 529篇 |
药学 | 1889篇 |
中国医学 | 40篇 |
肿瘤学 | 1328篇 |
出版年
2023年 | 130篇 |
2021年 | 197篇 |
2020年 | 184篇 |
2019年 | 253篇 |
2018年 | 396篇 |
2017年 | 368篇 |
2016年 | 484篇 |
2015年 | 545篇 |
2014年 | 530篇 |
2013年 | 816篇 |
2012年 | 1292篇 |
2011年 | 1265篇 |
2010年 | 721篇 |
2009年 | 613篇 |
2008年 | 1133篇 |
2007年 | 1243篇 |
2006年 | 1228篇 |
2005年 | 1179篇 |
2004年 | 1134篇 |
2003年 | 1062篇 |
2002年 | 1036篇 |
2001年 | 814篇 |
2000年 | 897篇 |
1999年 | 761篇 |
1998年 | 265篇 |
1997年 | 205篇 |
1996年 | 171篇 |
1995年 | 121篇 |
1992年 | 348篇 |
1991年 | 379篇 |
1990年 | 360篇 |
1989年 | 321篇 |
1988年 | 269篇 |
1987年 | 278篇 |
1986年 | 234篇 |
1985年 | 242篇 |
1984年 | 186篇 |
1983年 | 123篇 |
1982年 | 122篇 |
1979年 | 196篇 |
1978年 | 142篇 |
1977年 | 124篇 |
1975年 | 151篇 |
1974年 | 136篇 |
1973年 | 157篇 |
1972年 | 144篇 |
1971年 | 130篇 |
1970年 | 132篇 |
1969年 | 123篇 |
1967年 | 119篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
2.
3.
4.
5.
More than just crushing: a prospective pre‐post intervention study to reduce drug preparation errors in patients with feeding tubes 下载免费PDF全文
6.
7.
Poor results after surgery for bronchioloalveolar carcinoma. 总被引:2,自引:0,他引:2
R A M Damhuis P R Schütte O C M Varin P M van den Berg R Heinhuis P W Plaisier 《European journal of surgical oncology》2006,32(5):573-576
BACKGROUND: Bronchioloalveolar carcinoma (BAC) is suggested to be less aggressive than other types of lung cancer. To assess the option of treatment modification, actual outcome data were studied and compared with results for other types of lung cancer. METHOD: Retrospective analysis of all consecutive patients who underwent resection for stage I lung cancer in our hospital. For 18 BAC cases, histological specimens were re-evaluated and in three cases diagnosis was revised. RESULTS: In the period 1989 through 2000, 15 patients with BAC and 260 patients with other tumour types underwent surgery in our hospital. Five-year survival rates were 24 and 53%, respectively, (p = 0.01). CONCLUSIONS: Given the poor results after standard surgery, parenchyma-sparing operations do not seem justified in patients with invasive BAC. 相似文献
8.
9.
Claudia Gedlicka Gudrun Hager Martina Weissenböck Wilhelm Gedlicka Birgit Knerer Johannes Kornfehl Michael Formanek 《Journal of oral pathology & medicine》2006,35(8):472-478
BACKGROUND: 1Alpha,25-dihydroxyvitamin D(3) [1,25(OH)(2) Vitamin D(3)] induces growth inhibition in squamous cell carcinoma (SCC) cell lines of the head and neck by arresting the cells in the G0/G1 phase of the cell cycle, probably due to an enhanced expression of p21, which could be demonstrated in other cell lines (JPPA, SCC9) before. In SCC25, a SCC cell line isolated from tongue, growth inhibition but no overexpression of p21 was detected. The retinoblastoma gene, as a direct target of G1 cyclin-CDK complexes, showed an obvious shift from the hyperphosphorylated to the hypophosphorylated form under 1,25(OH)(2)Vitamin D(3), which indicates that the growth inhibition takes place in the G0/G1 phase. To explore the possible pathway of growth inhibition in SCC25 we investigated other cell cycle inhibitors (p18, p19, p27). METHODS: Synchronized cells were treated with 1,25(OH)(2)Vitamin D(3) over 96 h. The cell cycle status and expression of cell cycle-regulating proteins was determined by fluorescence-activated cell sorting (FACS) and Western blotting. An overexpression of p18 in 1,25(OH)(2)Vitamin D(3) vs. ethanol-treated cells was determined until 30 h in SCC25. No influence was detectable on the expression of p27 and p19. CONCLUSION: One mechanism by which 1,25(OH)(2)Vitamin D(3) controls cell growth might be the upregulation of p21. As p21 was unsusceptible to 1,25(OH)(2)Vitamin D(3) in SCC25, other inhibiting proteins were necessary to be tested. The proven upregulation of p18 seems to be the responsible step for growth inhibition of 1,25(OH)(2)Vitamin D(3) in SCC25. 相似文献
10.
C Schmitt J Brachmann W Saggau T Beyer B Waldecker K Scharowski T Hilbel M Montero B Offner W Sch?ls 《Zeitschrift für Kardiologie》1991,80(11):665-672
In 41 patients with recurrent sustained ventricular tachycardia and/or ventricular fibrillation an integrated pacemaker-defibrillator-system (PCD, Medtronic, model 7216 A or 7217 B) was implanted. In 21 out of 24 (88%) patients a new transvenous implantation technique in combination with a subcutaneous patch electrode was used. The implanted devices comprise antibradycardiac pacemaker functions, two different forms of antitachycardiac pacemaker functions (ramp and burst pacing), and internal cardioversion or defibrillation capabilities. During a mean follow-up of 8 months 147 episodes of ventricular tachycardia were detected, 131 of them were terminated successfully by antitachycardiac pacing; in 13 episodes internal cardioversion was applied to revert ventricular tachycardia. Twenty-seven episodes of ventricular fibrillation or rapid ventricular tachycardia (greater than 200/min) were detected and successfully terminated by internal defibrillation. In six patients with intermittent rapid atrial fibrillation, change of antiarrhythmic therapy was required to avoid activation of the device. The new integrated pacemaker-defibrillator systems improve therapy in patients with life-threatening tachyarrhythmias by reducing the number of internal cardioversions/defibrillations; the non-thoracotomy approach reduces the post operative risk. 相似文献